BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7575631)

  • 1. Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure.
    Matsumoto Y; Shinzato T; Amano I; Takai I; Kimura Y; Morita H; Miwa M; Nakane K; Yoshikai Y; Maeda K
    Biochem Biophys Res Commun; 1995 Oct; 215(1):98-105. PubMed ID: 7575631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system.
    Jaber BL; Perianayagam MC; Balakrishnan VS; King AJ; Pereira BJ
    J Leukoc Biol; 2001 Jun; 69(6):1006-12. PubMed ID: 11404388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
    Aggarwal S; Gupta S
    J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of Bcl-2 and Fas and apoptosis of T lymphocyte in the peripheral blood of patients with end-stage renal diseases].
    Xie DQ; Du YP; Liu M; Zeng L; Gan H; Chen LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):406-9. PubMed ID: 18575326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apoptosis in uremic complication].
    Matsumoto Y; Shinzato T; Amano I; Maeda K
    Rinsho Byori; 1997 Jul; 45(7):638-42. PubMed ID: 9256009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apoptosis in patients with chronic renal failure (CRF)].
    Makulska I; Zwolińska D; Chybicka A; Noworolska D
    Przegl Lek; 2006; 63 Suppl 3():180-3. PubMed ID: 16898524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
    Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
    J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.
    Boudet F; Lecoeur H; Gougeon ML
    J Immunol; 1996 Mar; 156(6):2282-93. PubMed ID: 8690919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies.
    Borges A; Borges M; Fernandes J; Nascimento H; Sameiro-Faria M; Miranda V; Reis F; Belo L; Costa E; Santos-Silva A
    Ren Fail; 2011; 33(2):138-43. PubMed ID: 21332334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype.
    Gougeon ML; Lecoeur H; Boudet F; Ledru E; Marzabal S; Boullier S; Roué R; Nagata S; Heeney J
    J Immunol; 1997 Mar; 158(6):2964-76. PubMed ID: 9058836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
    Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
    Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients.
    Trzonkowski P; Debska-Slizien A; Szmit E; Myśliwska J; Szymańska K; Hak Ł; Myśliwski A; Rutkowski B
    Nephrol Dial Transplant; 2005 Feb; 20(2):367-76. PubMed ID: 15585513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
    Van Parijs L; Biuckians A; Abbas AK
    J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
    Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
    J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease.
    Bariş YS; Yildiz L; Sentürk N; Kandemir B
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.